Empirical Ventures
VC Fund
Bristol, United Kingdom
Empirical Ventures is a VC fund in Bristol focused on Biotechnology and Medical. Empirical Ventures supports innovative approaches to critical problems in the fields of biotechnology and life sciences.
- Total investments:
- 39
- Last investment:
- Lead investor:
- 33%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Empirical Ventures invests in
Stages Empirical Ventures invests in
Countries Empirical Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $924k–$5.8M
- Pre-Seed
- $1.1M–$1.6M
Investment Focus
Industry
- Biotechnology 7 (18%)
- Medical 6 (15%)
- Health Care 4 (10%)
- Medical Device 4 (10%)
- AgTech 2 (5%)
Stage
- Seed 25 (64%)
- Pre-Seed 2 (5%)
- Funding Round 2 (5%)
- Series A 1 (3%)
- Venture - Series Unknown 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jonathan Matlock
Co-Founder
|
Co-Founder | Total investments: 12 | Find email | |
Johnathan Matlock
Co-Founder
|
Co-Founder | Total investments: 9 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Nuclear Turbine
|
Nuclear Turbines is an energy firm that is creating tiny modular nuclear technologies to make clean nuclear power more affordable than fossil fuels. | $20M / Seed / Jul 27, 2026 | |
|
Healome Therapeutics
|
Healome Therapeutics | $2.7M / Seed / Jul 07, 2026 | |
Neuronostics
|
Neuronostics Ltd is a newly established University of Exeter (UK) spin-out, focussed on the development and commercialisation of a novel and potentially revolutionary seizure susceptibility assessment technology called #BioEP. | $4M / Seed / Jun 30, 2026 | |
Silveray
|
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market. | $6.6M / Series A / Jun 17, 2026 | |
Caudal Energy
|
Porpoise Power develops a tidal energy system using oscillating hydrofoil technology inspired by dolphin swimming mechanics. | $5.8M / Seed / May 27, 2026 | |
Fermtech
|
Fermtech provides equipment for precision fermentation companies to scale production processes. Fermtech was founded in 2022 and was headquartered in Oxford, England. | $3.3M / Seed / Apr 07, 2026 | |
Orthofuse
|
Orthofuse is a medtech company that provides orthopaedic solutions using 3D-printed implant systems designed to improve the safety and efficiency of surgical procedures. | $3M / Seed / Feb 12, 2026 | |
QV Bioelectronics
|
Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Ourco-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients. | $6M / Jan 21, 2026 | |
HotGreen Solutions
|
HotGreen is an industrial high-temperature heat pump company providing process heat from electricity. | $1.6M / Pre-Seed / Oct 14, 2025 | |
EnsiliTech
|
EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials. | $6.1M / Seed / Aug 28, 2025 | |
| See all 39 investments → | |||
Co-Investors
Science Angel Syndicate
14 deals together
Elbow Beach Capital
10 deals together
ACF Investors
5 deals together
Bristol Private Equity Club
5 deals together
Northern Gritstone
5 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Empirical Ventures invest in?
Empirical Ventures invests primarily in Biotechnology, Medical and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 39 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Empirical Ventures's check size?
Empirical Ventures typically joins rounds of $924k–$5.8M at Seed and $1.1M–$1.6M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Empirical Ventures participates in.
How do I contact Empirical Ventures?
Public channels for Empirical Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Empirical Ventures?
The team at Empirical Ventures includes Jonathan Matlock (Co-Founder) and Johnathan Matlock (Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
